Andreia D. MENEZES & Nelson A. FRAIJI. (2020). Use of tyrosine kinase inhibitor by patients with chronic myeloid leukemia at a public hematology institution in the state of Amazonas, Brazil. Sociedade Brasileira de Farmácia Hospitalar e Serviços de Saúde.
Chicago Style (17th ed.) CitationAndreia D. MENEZES and Nelson A. FRAIJI. Use of Tyrosine Kinase Inhibitor by Patients with Chronic Myeloid Leukemia at a Public Hematology Institution in the State of Amazonas, Brazil. Sociedade Brasileira de Farmácia Hospitalar e Serviços de Saúde, 2020.
MLA (9th ed.) CitationAndreia D. MENEZES and Nelson A. FRAIJI. Use of Tyrosine Kinase Inhibitor by Patients with Chronic Myeloid Leukemia at a Public Hematology Institution in the State of Amazonas, Brazil. Sociedade Brasileira de Farmácia Hospitalar e Serviços de Saúde, 2020.